Vaccine approved for shingles in older people.
A new vaccine called Zostavax is available to reduce the risk of shingles (herpes zoster) in people ages 60 and older.
D000368:Aged; D006562:Herpes Zoster / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged
D053061:Herpes Zoster Vaccine